Left atrial strain by vendor-neutral echocardiography software in healthy subjects: vendor comparisons and associated factors

在健康受试者中,使用厂商中立的超声心动图软件测量左心房应变:厂商比较及相关因素

阅读:1

Abstract

AIMS: Left atrial strains [reservoir (LASr), conduit (LAScd), and contractile (LASct)] are increasingly utilized, primarily in the areas of heart failure and valvulopathy. Commercially available software to measure strain are marketed as imaging machine vendor independent, although the normal ranges of their performance and external validation studies are lacking. We evaluated and compared LAS values, reference ranges, and associated factors using contemporary strain software. METHODS AND RESULTS: Healthy subjects (n = 100) undergoing transthoracic echocardiography during January to April 2023 were studied, with equal number by age groups, sex, and GE vs. Philips equipment. LASs were quantified using TomTec version 51.02 (AutoStrain LA), EchoPAC version 206 (AFILA), velocity vector imaging (VVI) version 2.00, and Epsilon version 5.0.2.11295 software. Means and lower limits of normal [95% confidence interval (CI)] of LASr (%) were 44.1 (41.9, 46.3) and 30.3 (26.4, 34.1) for TomTec; 34.8 (33.6, 36.0) and 26.3 (24.2, 28.4) for EchoPAC (on GE scans only); 42.5 (40.2, 44.8) and 28.4 (24.4, 32.4) for VVI; and 37.0 (34.9, 39.1) and 25.2 (21.5, 28.8) for Epsilon. Factors significantly associated with variability in LASr measurements and their beta-coefficients (95% CI) were age -2.37 (-3.41, -1.33) per 10 years, EchoPAC (vs. TomTec) -9.63 (-12.75, -6.51), and Epsilon (vs. TomTec) -7.04 (-9.40, -4.67). Reference ranges and factors significantly associated with LAScd and LASct were reported. LAS measurements and normal ranges by strain software and associated clinical and echocardiographic factors were determined. CONCLUSION: EchoPAC and Epsilon have lower magnitude mean LAS values compared with TomTec and VVI, and all software were vendor neutral except EchoPAC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。